As of Sep 26
| -1.45 / -1.13%|
The 23 analysts offering 12-month price forecasts for Zimmer Biomet Holdings Inc have a median target of 145.00, with a high estimate of 155.00 and a low estimate of 95.00. The median estimate represents a +14.28% increase from the last price of 126.88.
The current consensus among 27 polled investment analysts is to Buy stock in Zimmer Biomet Holdings Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.